Loading...

George Kaysen

Title(s)Professor, Nephrology
SchoolUniversity of California, Davis
Phone530-752-4010
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zhu F, Kaysen GA, Sarkar S, Finkelstein FO, Carter M, Levin NW, Hoenich NA. Evaluation of one year of frequent dialysis on fluid load and body composition using calf bioimpedance technique. Physiol Meas. 2019 Jun 04; 40(5):055004. PMID: 31035269.
      View in: PubMed
    2. Chiang JM, Kaysen GA, Segal M, Chertow GM, Delgado C, Johansen KL. Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis. Nephrol Dial Transplant. 2019 May 01; 34(5):802-810. PMID: 30085235.
      View in: PubMed
    3. Huang SS, Kaysen GA, Levin NW, Kliger AS, Beck GJ, Rocco MV, Filler G, Lindsay RM. The effect of increased frequency of hemodialysis on serum cystatin C and ß2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial. Hemodial Int. 2019 Jul; 23(3):297-305. PMID: 30861262.
      View in: PubMed
    4. Johansen KL, Delgado C, Kaysen GA, Chertow GM, Chiang J, Dalrymple LS, Segal MR, Grimes BA. Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality. J Gerontol A Biol Sci Med Sci. 2019 Feb 15; 74(3):380-386. PMID: 30192916.
      View in: PubMed
    5. Molfino A, Beck GJ, Li M, Lo JC, Kaysen GA. Association between change in serum bicarbonate and change in thyroid hormone levels in patients receiving conventional or more frequent maintenance haemodialysis. Nephrology (Carlton). 2019 Jan; 24(1):81-87. PMID: 29064128.
      View in: PubMed
    6. Kaysen GA, Ye X, Raimann JG, Wang Y, Topping A, Usvyat LA, Stuard S, Canaud B, van der Sande FM, Kooman JP, Kotanko P. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results. J Lipid Res. 2018 08; 59(8):1519-1528. PMID: 29895699.
      View in: PubMed
    7. van Gelder MK, Abrahams AC, Joles JA, Kaysen GA, Gerritsen KGF. Albumin handling in different hemodialysis modalities. Nephrol Dial Transplant. 2018 06 01; 33(6):906-913. PMID: 29106652.
      View in: PubMed
    8. Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials. Am J Nephrol. 2018; 47(3):208-217. PMID: 29621747.
      View in: PubMed
    9. Chiang JM, Kaysen GA, Schafer AL, Delgado C, Johansen KL. Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue. J Ren Nutr. 2018 07; 28(4):278-282. PMID: 29606304.
      View in: PubMed
    10. Madan N, Kaysen GA. Gut Endothelial Leakage of Endotoxin May Be the Source of Vascular Inflammation and Injury in CKD. How Can This Be Targeted? J Ren Nutr. 2018 01; 28(1):1-3. PMID: 29249294.
      View in: PubMed
    11. Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T, Johansen KL. Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. J Clin Lipidol. 2018 Mar - Apr; 12(2):481-487.e14. PMID: 29361496.
      View in: PubMed
    12. Delgado C, Chertow GM, Kaysen GA, Dalrymple LS, Kornak J, Grimes B, Johansen KL. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis. Am J Kidney Dis. 2017 Dec; 70(6):817-825. PMID: 28870376.
      View in: PubMed
    13. Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, Grimes B, Kaysen GA. Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1100-1108. PMID: 28576906.
      View in: PubMed
    14. Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017 07; 92(1):238-247. PMID: 28318630.
      View in: PubMed
    15. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541. PMID: 28301073.
      View in: PubMed
    16. Krishnan S, Shimoda M, Sacchi R, Kailemia MJ, Luxardi G, Kaysen GA, Parikh AN, Ngassam VN, Johansen K, Chertow GM, Grimes B, Smilowitz JT, Maverakis E, Lebrilla CB, Zivkovic AM. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. Sci Rep. 2017 03 13; 7:43728. PMID: 28287093.
      View in: PubMed
    17. Kaysen GA. Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients. Blood Purif. 2017; 43(1-3):196-199. PMID: 28114129.
      View in: PubMed
    18. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 04; 21(2):190-196. PMID: 27774730.
      View in: PubMed
    19. Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017 Feb; 8(1):57-68. PMID: 27897415.
      View in: PubMed
    20. Ananthakrishnan S, Kaysen GA. Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale. Adv Chronic Kidney Dis. 2016 07; 23(4):247-54. PMID: 27324678.
      View in: PubMed
    21. Abreo AP, Dalrymple LS, Chertow GM, Kaysen GA, Herzog CA, Johansen KL. Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis. Hemodial Int. 2017 01; 21(1):133-141. PMID: 27346666.
      View in: PubMed
    22. Unruh ML, Larive B, Eggers PW, Garg AX, Gassman JJ, Finkelstein FO, Kimmel PL, Chertow GM. The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials. Nephrol Dial Transplant. 2016 06; 31(6):984-91. PMID: 27190356.
      View in: PubMed
    23. Kutner NG, Zhang R, Huang Y, Kaysen GA, Park J. Lower C-reactive protein and better hemodialysis survival are associated with regular exercise activity: Longitudinal outcomes from the ACTIVE-ADIPOSE special study. Hemodial Int. 2016 07; 20(3):473-83. PMID: 26954723.
      View in: PubMed
    24. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif. 2016; 41(4):277-86. PMID: 26795100.
      View in: PubMed
    25. Johansen KL, Dalrymple LS, Glidden D, Delgado C, Kaysen GA, Grimes B, Chertow GM. Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):626-32. PMID: 26792529.
      View in: PubMed
    26. Kittiskulnam P, Chertow GM, Kaysen GA, Delgado C, Dalrymple LS, Johansen KL. Misclassification of Obesity by Body Mass Index Among Patients Receiving Hemodialysis. Am J Kidney Dis. 2016 Apr; 67(4):709-11. PMID: 26612278.
      View in: PubMed
    27. Dalrymple LS, Mu Y, Nguyen DV, Romano PS, Chertow GM, Grimes B, Kaysen GA, Johansen KL. Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis. Clin J Am Soc Nephrol. 2015 Dec 07; 10(12):2170-80. PMID: 26567370.
      View in: PubMed
    28. Molfino A, Kaysen GA, Chertow GM, Doyle J, Delgado C, Dwyer T, Laviano A, Rossi Fanelli F, Johansen KL. Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis. J Ren Nutr. 2016 Mar; 26(2):103-10. PMID: 26522141.
      View in: PubMed
    29. Delgado C, Shieh S, Grimes B, Chertow GM, Dalrymple LS, Kaysen GA, Kornak J, Johansen KL. Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis. Am J Nephrol. 2015; 42(2):134-40. PMID: 26381744.
      View in: PubMed
    30. Abreo AP, Chertow GM, Dalrymple LS, Kaysen GA, Johansen KL. Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis. Hemodial Int. 2015 Oct; 19(4):536-42. PMID: 25881673.
      View in: PubMed
    31. Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J Ren Nutr. 2015 Jul; 25(4):351-6. PMID: 25802017.
      View in: PubMed
    32. Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, Grimes B, Kaysen GA, Johansen KL. Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis. Am J Kidney Dis. 2015 May; 65(5):754-62. PMID: 25641061.
      View in: PubMed
    33. Raimann JG, Abbas SR, Liu L, Zhu F, Larive B, Kotanko P, Levin NW, Kaysen GA. Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the Frequent Hemodialysis Network Daily Trial. Nephron Clin Pract. 2014; 128(1-2):115-26. PMID: 25402657.
      View in: PubMed
    34. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int. 2015 Jan; 87(1):169-75. PMID: 25029429.
      View in: PubMed
    35. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014 Oct; 64(4):600-7. PMID: 24793033.
      View in: PubMed
    36. Abbas SR, Zhu F, Kaysen GA, Kotanko P, Levin NW. Effect of change in fluid distribution in segments in hemodialysis patients at different ultrafiltration rates on accuracy of whole body bioimpedance measurement. J Appl Physiol (1985). 2014 Jun 01; 116(11):1382-9. PMID: 24674858.
      View in: PubMed
    37. Delgado C, Ward P, Chertow GM, Storer L, Dalrymple L, Block T, Kaysen GA, Kornak J, Grimes B, Kutner NG, Johansen KL. Calibration of the brief food frequency questionnaire among patients on dialysis. J Ren Nutr. 2014 May; 24(3):151-156.e1. PMID: 24613023.
      View in: PubMed
    38. Kaysen GA. Progressive inflammation and wasting in patients with ESRD. Clin J Am Soc Nephrol. 2014 Feb; 9(2):225-6. PMID: 24458072.
      View in: PubMed
    39. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014 Jan; 9(1):73-81. PMID: 24370770.
      View in: PubMed
    40. Kaysen GA, Chin A. If oxidative stress is an appropriate and specific target, what reagent should we choose? J Am Soc Nephrol. 2014 Mar; 25(3):427-9. PMID: 24357667.
      View in: PubMed
    41. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol. 2014 Feb; 25(2):381-9. PMID: 24158987.
      View in: PubMed
    42. Raimann JG, Zhu F, Wang J, Thijssen S, Kuhlmann MK, Kotanko P, Levin NW, Kaysen GA. Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods. Kidney Int. 2014 Apr; 85(4):898-908. PMID: 24067432.
      View in: PubMed
    43. Kaysen GA, Dalrymple LS, Grimes B, Chertow GM, Kornak J, Johansen KL. Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):430-7. PMID: 24009290.
      View in: PubMed
    44. Anand S, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kaysen GA, Kurella Tamura M. Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study. J Ren Nutr. 2013 Nov; 23(6):422-7. PMID: 23876600.
      View in: PubMed
    45. Molfino A, Don BR, Kaysen GA. Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients. Nephron Clin Pract. 2012; 122(3-4):127-33. PMID: 23689544.
      View in: PubMed
    46. Molfino A, Heymsfield SB, Zhu F, Kotanko P, Levin NW, Dwyer T, Kaysen GA. Prealbumin is associated with visceral fat mass in patients receiving hemodialysis. J Ren Nutr. 2013 Nov; 23(6):406-10. PMID: 23623396.
      View in: PubMed
    47. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY, ter Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar; 23(2):77-90. PMID: 23428357.
      View in: PubMed
    48. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013 May; 83(5):949-58. PMID: 23344474.
      View in: PubMed
    49. Kaysen GA, Odabaei G. Dietary protein restriction and preservation of kidney function in chronic kidney disease. Blood Purif. 2013; 35(1-3):22-5. PMID: 23343542.
      View in: PubMed
    50. Sentürk D, Dalrymple LS, Mohammed SM, Kaysen GA, Nguyen DV. Modeling time-varying effects with generalized and unsynchronized longitudinal data. Stat Med. 2013 Jul 30; 32(17):2971-87. PMID: 23335196.
      View in: PubMed
    51. Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, Chertow GM. Association of physical activity with survival among ambulatory patients on dialysis: the Comprehensive Dialysis Study. Clin J Am Soc Nephrol. 2013 Feb; 8(2):248-53. PMID: 23124787.
      View in: PubMed
    52. Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med. 2012 Jul 23; 172(14):1071-7. PMID: 22733312.
      View in: PubMed
    53. Anand S, Johansen KL, Grimes B, Kaysen GA, Dalrymple LS, Kutner NG, Chertow GM. Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study. Hemodial Int. 2013 Jan; 17(1):50-8. PMID: 22812496.
      View in: PubMed
    54. Wang L, Shearer GC, Budamagunta MS, Voss JC, Molfino A, Kaysen GA. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. Kidney Int. 2012 Nov; 82(9):990-9. PMID: 22785171.
      View in: PubMed
    55. Dalrymple LS, Johansen KL, Chertow GM, Grimes B, Anand S, McCulloch CE, Kaysen GA. Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study. J Ren Nutr. 2013 Mar; 23(2):91-7. PMID: 22633987.
      View in: PubMed
    56. Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int. 2012 Jul; 82(1):90-9. PMID: 22456602.
      View in: PubMed
    57. Dalrymple LS, Kaysen GA. Obesity and mortality on dialysis--does age matter? Nat Rev Nephrol. 2012 Mar 27; 8(5):258-60. PMID: 22450439.
      View in: PubMed
    58. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012 May; 7(5):782-94. PMID: 22422538.
      View in: PubMed
    59. Dalrymple LS, Mohammed SM, Mu Y, Johansen KL, Chertow GM, Grimes B, Kaysen GA, Nguyen DV. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1708-13. PMID: 21566109.
      View in: PubMed
    60. Anand S, Kaysen GA, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kurella Tamura M. Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant. 2011 Nov; 26(11):3683-8. PMID: 21430182.
      View in: PubMed
    61. Sriram R, Lagerstedt JO, Petrlova J, Samardzic H, Kreutzer U, Xie H, Kaysen GA, Desreux JF, Thonon D, Jacques V, Van Loan M, Rutledge JC, Oda MN, Voss JC, Jue T. Imaging apolipoprotein AI in vivo. NMR Biomed. 2011 Aug; 24(7):916-24. PMID: 21264979.
      View in: PubMed
    62. Anand S, Chertow GM, Johansen KL, Grimes B, Kurella Tamura M, Dalrymple LS, Kaysen GA. Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study. J Ren Nutr. 2011 Nov; 21(6):429-37. PMID: 21239185.
      View in: PubMed
    63. Kaysen GA. New insights into lipid metabolism in chronic kidney disease. J Ren Nutr. 2011 Jan; 21(1):120-3. PMID: 21195934.
      View in: PubMed
    64. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011 Jan; 57(1):101-12. PMID: 21184919.
      View in: PubMed
    65. Johansen KL, Chertow GM, Kutner NG, Dalrymple LS, Grimes BA, Kaysen GA. Low level of self-reported physical activity in ambulatory patients new to dialysis. Kidney Int. 2010 Dec; 78(11):1164-70. PMID: 20811334.
      View in: PubMed
    66. Bakris G, Vassalotti J, Ritz E, Wanner C, Stergiou G, Molitch M, Nesto R, Kaysen GA, Sowers JR. National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events. Kidney Int. 2010 Oct; 78(8):726-36. PMID: 20720529.
      View in: PubMed
    67. Dalrymple LS, Johansen KL, Chertow GM, Cheng SC, Grimes B, Gold EB, Kaysen GA. Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis. 2010 Sep; 56(3):522-30. PMID: 20619518.
      View in: PubMed
    68. Don BR, Kim K, Li J, Dwyer T, Alexander F, Kaysen GA. The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients. Clin Nephrol. 2010 Jun; 73(6):431-8. PMID: 20497755.
      View in: PubMed
    69. Kaysen GA. Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S56-63. PMID: 19996007.
      View in: PubMed
    70. Kaysen GA. Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease. Kidney Int. 2009 Aug; 76(4):359-61. PMID: 19644477.
      View in: PubMed
    71. Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, Dwyer T, Usvyat L, Havel P, Levin NW. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr. 2009 Sep; 19(5):357-64. PMID: 19596588.
      View in: PubMed
    72. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009 Jun; 20(6):1199-209. PMID: 19470680.
      View in: PubMed
    73. Kutner NG, Johansen KL, Kaysen GA, Pederson S, Chen SC, Agodoa LY, Eggers PW, Chertow GM. The comprehensive dialysis study (CDS): a USRDS special study. Clin J Am Soc Nephrol. 2009 Mar; 4(3):645-50. PMID: 19261814.
      View in: PubMed
    74. Kaysen GA. New insights into lipid metabolism in chronic kidney disease: what are the practical implications? Blood Purif. 2009; 27(1):86-91. PMID: 19169024.
      View in: PubMed
    75. Kaysen GA. Lipid and lipoprotein metabolism in chronic kidney disease. J Ren Nutr. 2009 Jan; 19(1):73-7. PMID: 19121776.
      View in: PubMed
    76. Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, Levin NW. Estimation of adipose pools in hemodialysis patients from anthropometric measures. J Ren Nutr. 2008 Nov; 18(6):473-8. PMID: 18940649.
      View in: PubMed
    77. Kaysen GA, Johansen KL, Cheng SC, Jin C, Chertow GM. Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. J Ren Nutr. 2008 Jul; 18(4):323-31. PMID: 18558296.
      View in: PubMed
    78. Dalrymple LS, Kaysen GA. The effect of lipoproteins on the development and progression of renal disease. Am J Nephrol. 2008; 28(5):723-31. PMID: 18434711.
      View in: PubMed
    79. Hsu J, Johansen KL, Hsu CY, Kaysen GA, Chertow GM. Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol. 2008 Jul; 3(4):992-7. PMID: 18417750.
      View in: PubMed
    80. Macdougall IC, Walker R, Provenzano R, de Alvaro F, Locay HR, Nader PC, Locatelli F, Dougherty FC, Beyer U. C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Clin J Am Soc Nephrol. 2008 Mar; 3(2):337-47. PMID: 18287255.
      View in: PubMed
    81. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Trevinho-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008 Feb; 73(4):391-8. PMID: 18094682.
      View in: PubMed
    82. Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs. 2007 Nov; 30(11):987-92. PMID: 18067100.
      View in: PubMed
    83. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial. 2007 Nov-Dec; 20(6):586-92. PMID: 17991209.
      View in: PubMed
    84. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80. PMID: 17971309.
      View in: PubMed
    85. Kaysen GA. Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance. Kidney Int. 2007 Oct; 72(7):779-81. PMID: 17882238.
      View in: PubMed
    86. Lo JC, Go AS, Chandra M, Fan D, Kaysen GA. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8. PMID: 17900454.
      View in: PubMed
    87. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci. 2007 Nov; 100(1):303-15. PMID: 17709331.
      View in: PubMed
    88. Newman JW, Kaysen GA, Hammock BD, Shearer GC. Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat. J Lipid Res. 2007 Aug; 48(8):1792-800. PMID: 17496268.
      View in: PubMed
    89. Kaysen GA. Disorders in high-density metabolism with insulin resistance and chronic kidney disease. J Ren Nutr. 2007 Jan; 17(1):4-8. PMID: 17198924.
      View in: PubMed
    90. Kaysen GA, Levin NW, Mitch WE, Chapman AL, Kubala L, Eiserich JP. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients. Blood Purif. 2006; 24(5-6):508-16. PMID: 17077623.
      View in: PubMed
    91. Sarkar SR, Kuhlmann MK, Kotanko P, Zhu F, Heymsfield SB, Wang J, Meisels IS, Gotch FA, Kaysen GA, Levin NW. Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int. 2006 Nov; 70(10):1832-9. PMID: 17021607.
      View in: PubMed
    92. Kaysen GA. Metabolic syndrome and renal failure: similarities and differences. Panminerva Med. 2006 Sep; 48(3):151-64. PMID: 17122751.
      View in: PubMed
    93. Shearer GC, Kaysen GA. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion. Kidney Int. 2006 Aug; 70(4):647-53. PMID: 16807550.
      View in: PubMed
    94. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis. 2006 Jan; 47(1):131-8. PMID: 16377394.
      View in: PubMed
    95. Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif. 2006; 24(1):51-5. PMID: 16361841.
      View in: PubMed
    96. Kaysen GA, Müller HG, Ding J, Chertow GM. Challenging the validity of the EPO index. Am J Kidney Dis. 2006 Jan; 47(1):166. PMID: 16377397.
      View in: PubMed
    97. Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int. 2005 Dec; 68(6):2794-800. PMID: 16316355.
      View in: PubMed
    98. Kaysen GA, Zhu F, Sarkar S, Heymsfield SB, Wong J, Kaitwatcharachai C, Kuhlmann MK, Levin NW. Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy. Am J Clin Nutr. 2005 Nov; 82(5):988-95. PMID: 16280429.
      View in: PubMed
    99. Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol. 2005 Nov; 57(11):1407-13. PMID: 16259772.
      View in: PubMed
    100. Kaysen GA. Diabetes, a cause of progressive sarcopenia in dialysis patients? Kidney Int. 2005 Nov; 68(5):2396-7. PMID: 16221246.
      View in: PubMed
    101. Zhu F, Kuhlmann MK, Kaysen GA, Sarkar S, Kaitwatcharachai C, Khilnani R, Stevens L, Leonard EF, Wang J, Heymsfield S, Levin NW. Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients. J Appl Physiol (1985). 2006 Feb; 100(2):717-24. PMID: 16254072.
      View in: PubMed
    102. Shearer GC, Newman JW, Hammock BD, Kaysen GA. Graded effects of proteinuria on HDL structure in nephrotic rats. J Am Soc Nephrol. 2005 May; 16(5):1309-19. PMID: 15788471.
      View in: PubMed
    103. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant. 2005 Jun; 20(6):1180-6. PMID: 15769823.
      View in: PubMed
    104. Sarkar SR, Kuhlmann MK, Khilnani R, Zhu F, Heymsfield SB, Kaysen GA, Levin NW. Assessment of body composition in long-term hemodialysis patients: rationale and methodology. J Ren Nutr. 2005 Jan; 15(1):152-8. PMID: 15648026.
      View in: PubMed
    105. Kaysen GA. Effects of inflammation on plasma composition and endothelial structure and function. J Ren Nutr. 2005 Jan; 15(1):94-8. PMID: 15648015.
      View in: PubMed
    106. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec; 17(6):432-7. PMID: 15660573.
      View in: PubMed
    107. Kaysen GA. Inflammation: cause of vascular disease and malnutrition in dialysis patients. Semin Nephrol. 2004 Sep; 24(5):431-6. PMID: 15490405.
      View in: PubMed
    108. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004 Aug; 80(2):324-32. PMID: 15277152.
      View in: PubMed
    109. Rahmati MA, Homel P, Hoenich NA, Levin R, Kaysen GA, Levin NW. The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs. 2004 Aug; 27(8):723-7. PMID: 15478544.
      View in: PubMed
    110. Mehrotra R, Supasyndh O, Berman N, Kaysen G, Hurst L, Leonardi M, Das D, Kopple JD. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake. J Ren Nutr. 2004 Jul; 14(3):134-42. PMID: 15232791.
      View in: PubMed
    111. Kaysen GA, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004 Apr; 65(4):1408-15. PMID: 15086482.
      View in: PubMed
    112. Kaysen GA, Müller HG, Young BS, Leng X, Chertow GM. The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. J Ren Nutr. 2004 Apr; 14(2):72-81. PMID: 15060871.
      View in: PubMed
    113. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004 Mar; 15(3):538-48. PMID: 14978155.
      View in: PubMed
    114. Shearer GC, Couser WG, Kaysen GA. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL. Kidney Int. 2004 Jan; 65(1):228-37. PMID: 14675054.
      View in: PubMed
    115. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, Levin NW, Yan G. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 2003 Dec; 42(6):1200-11. PMID: 14655192.
      View in: PubMed
    116. Eriksson T, Höglund P, Turesson I, Waage A, Don BR, Vu J, Scheffler M, Kaysen GA. Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis. J Pharm Pharmacol. 2003 Dec; 55(12):1701-6. PMID: 14738599.
      View in: PubMed
    117. Kaysen GA. Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int Suppl. 2003 Nov; (87):S92-8. PMID: 14531780.
      View in: PubMed
    118. Kaysen GA, Eiserich JP. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial. 2003 Nov-Dec; 16(6):438-46. PMID: 14629602.
      View in: PubMed
    119. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin N. Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis. Semin Dial. 2003 Nov-Dec; 16(6):474-6. PMID: 14629609.
      View in: PubMed
    120. Prinsen BH, Rabelink TJ, Beutler JJ, Kaysen GA, De Boer J, Boer WH, Hagen EC, Berger R, De Sain-Van Der Velden MG. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 2003 Oct; 64(4):1495-504. PMID: 12969171.
      View in: PubMed
    121. Rahmati MA, Rahmati S, Hoenich N, Ronco C, Kaysen GA, Levin R, Levin NW. On-line clearance: a useful tool for monitoring the effectiveness of the reuse procedure. ASAIO J. 2003 Sep-Oct; 49(5):543-6. PMID: 14524561.
      View in: PubMed
    122. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003 Jul; 14(7):1863-70. PMID: 12819247.
      View in: PubMed
    123. Handelman GJ, Rosales LM, Barbato D, Luscher J, Adhikarla R, Nicolosi RJ, Finkelstein FO, Ronco C, Kaysen GA, Hoenich NA, Levin NW. Breath ethane in dialysis patients and control subjects. Free Radic Biol Med. 2003 Jul 01; 35(1):17-23. PMID: 12826252.
      View in: PubMed
    124. Zhu F, Hoenich NA, Kaysen G, Ronco C, Schneditz D, Murphy L, Santacroce S, Pangilinan A, Gotch F, Levin NW. Measurement of intraperitoneal volume by segmental bioimpedance analysis during peritoneal dialysis. Am J Kidney Dis. 2003 Jul; 42(1):167-72. PMID: 12830469.
      View in: PubMed
    125. Kaysen GA, Levin NW. Why measure serum albumin levels? Adv Ren Replace Ther. 2003 Jul; 10(3):228-31. PMID: 14708078.
      View in: PubMed
    126. Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int Suppl. 2003 May; (84):S94-7. PMID: 12694319.
      View in: PubMed
    127. Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences. J Ren Nutr. 2003 Apr; 13(2):158-60. PMID: 12671842.
      View in: PubMed
    128. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM. Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr. 2003 Apr; 77(4):842-6. PMID: 12663281.
      View in: PubMed
    129. Kumar VA, Yeun JY, Kaysen GA. Daily dialysis in North America: evidence for a bright future. Int J Artif Organs. 2003 Feb; 26(2):95-9. PMID: 12653341.
      View in: PubMed
    130. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin NW. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif. 2003; 21(1):51-7. PMID: 12566662.
      View in: PubMed
    131. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int. 2003 Jan; 63(1):315-22. PMID: 12472798.
      View in: PubMed
    132. Rahmati MA, Craig RG, Homel P, Kaysen GA, Levin NW. Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis. 2002 Nov; 40(5):983-9. PMID: 12407643.
      View in: PubMed
    133. Prinsen BH, Kaysen GA, Klomp LW, de Boer J, Barrett PH, Thornalley PJ, Battah S, Berger R, Rabelink TJ, de Sain-van der Velden MG. Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate. Clin Biochem. 2002 Oct; 35(7):545-53. PMID: 12493583.
      View in: PubMed
    134. Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis. 2002 Oct; 40(4):721-7. PMID: 12324906.
      View in: PubMed
    135. Schneditz D, Rosales L, Kaufman AM, Kaysen G, Levin NW. Heat accumulation with relative blood volume decrease. Am J Kidney Dis. 2002 Oct; 40(4):777-82. PMID: 12324913.
      View in: PubMed
    136. Kaysen GA, Levin NW. Why measure serum albumin levels? J Ren Nutr. 2002 Jul; 12(3):148-50. PMID: 12105811.
      View in: PubMed
    137. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002 Jun; 61(6):2240-9. PMID: 12028466.
      View in: PubMed
    138. Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif. 2002; 20(1):70-80. PMID: 11803162.
      View in: PubMed
    139. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Levin NW. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int. 2001 Dec; 60(6):2360-6. PMID: 11737611.
      View in: PubMed
    140. Shearer GC, Couser WG, Kaysen GA. Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis. Am J Kidney Dis. 2001 Dec; 38(6):1385-9. PMID: 11728980.
      View in: PubMed
    141. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int. 2001 Jul; 60(1):333-40. PMID: 11422769.
      View in: PubMed
    142. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001 Jul; 12(7):1549-57. PMID: 11423586.
      View in: PubMed
    143. Prinsen BH, de Sain-van der Velden MG, Kaysen GA, Straver HW, van Rijn HJ, Stellaard F, Berger R, Rabelink TJ. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol. 2001 May; 12(5):1017-25. PMID: 11316861.
      View in: PubMed
    144. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int. 2001 Mar; 59(3):1114-20. PMID: 11231368.
      View in: PubMed
    145. Shearer GC, Stevenson FT, Atkinson DN, Jones H, Staprans I, Kaysen GA. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int. 2001 Jan; 59(1):179-89. PMID: 11135070.
      View in: PubMed
    146. Shearer GC, Kaysen GA. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms. Am J Kidney Dis. 2001 Jan; 37(1 Suppl 2):S119-22. PMID: 11158876.
      View in: PubMed
    147. Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens. 2000 Nov; 9(6):621-30. PMID: 11128424.
      View in: PubMed
    148. Kaysen GA. Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish. Nephrol Dial Transplant. 2000 Oct; 15(10):1521-4. PMID: 11007817.
      View in: PubMed
    149. Don BR, Kaysen GA. Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol. 2000 Jul-Aug; 13(4):249-59. PMID: 10946803.
      View in: PubMed
    150. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000 Jul; 15(7):953-60. PMID: 10862630.
      View in: PubMed
    151. Kaysen GA, Dubin JA, Müller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int. 2000 Jul; 58(1):346-52. PMID: 10886581.
      View in: PubMed
    152. de Sain-Van Der Velden MG, de Meer K, Kulik W, Melissant CF, Rabelink TJ, Berger R, Kaysen GA. Nephrotic proteinuria has No net effect on total body protein synthesis: measurements with (13)C valine. Am J Kidney Dis. 2000 Jun; 35(6):1149-54. PMID: 10845830.
      View in: PubMed
    153. Shearer GC, Joles JA, Jones H, Walzem RL, Kaysen GA. Estrogen effects on triglyceride metabolism in analbuminemic rats. Kidney Int. 2000 Jun; 57(6):2268-74. PMID: 10844597.
      View in: PubMed
    154. Stevenson FT, Wheeldon CM, Gades MD, Kaysen GA, Stern JS, van Goor H. Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat. Kidney Int. 2000 May; 57(5):1927-35. PMID: 10792611.
      View in: PubMed
    155. Kaysen GA. C-reactive protein: a story half told. Semin Dial. 2000 May-Jun; 13(3):143-6. PMID: 10833771.
      View in: PubMed
    156. Perez RV, Brown DJ, Katznelson SA, Dubin JA, Müller HG, Chang T, Rudich SM, McVicar JP, Kaysen GA. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation. 2000 Mar 15; 69(5):869-74. PMID: 10755542.
      View in: PubMed
    157. Kaysen GA. Interpretation of plasma protein measurements in end-stage renal disease. Blood Purif. 2000; 18(4):337-42. PMID: 10965078.
      View in: PubMed
    158. Kaysen GA. Inflammation and oxidative stress in end-stage renal disease. Adv Nephrol Necker Hosp. 2000; 30:201-14. PMID: 11068643.
      View in: PubMed
    159. Gades MD, Van Goor H, Kaysen GA, Johnson PR, Horwitz BA, Stern JS. Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int. 1999 Nov; 56(5):1779-87. PMID: 10571786.
      View in: PubMed
    160. Kang J, Holland M, Jones H, Kaysen GA. Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states. Kidney Int. 1999 Aug; 56(2):452-60. PMID: 10432383.
      View in: PubMed
    161. Kaysen GA. Inflammation nutritional state and outcome in end stage renal disease. Miner Electrolyte Metab. 1999 Jul-Dec; 25(4-6):242-50. PMID: 10681647.
      View in: PubMed
    162. Kaysen GA, de Sain-van der Velden MG. New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl. 1999 Jul; 71:S18-21. PMID: 10412729.
      View in: PubMed
    163. Borchers AT, Perez R, Kaysen G, Ansari AA, Gershwin ME. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms. Transpl Immunol. 1999 Jun; 7(2):75-82. PMID: 10544437.
      View in: PubMed
    164. Stevenson FT, Kaysen GA. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment. Wien Klin Wochenschr. 1999 Apr 23; 111(8):307-14. PMID: 10378311.
      View in: PubMed
    165. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999 Jan; 33(1):63-72. PMID: 9915269.
      View in: PubMed
    166. van Goor H, Diamond JR, Ding G, Kaysen G. Alpha macroglobulins and the low-density-lipoprotein-related protein/alpha-2-macroglobulin receptor in experimental renal fibrosis. Exp Nephrol. 1999 Jan-Feb; 7(1):35-43. PMID: 9892812.
      View in: PubMed
    167. Kaysen GA. Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol. 1998 Dec; 9(12):2368-76. PMID: 9848794.
      View in: PubMed
    168. Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. 1998 Dec; 32(6 Suppl 4):S118-25. PMID: 9892378.
      View in: PubMed
    169. De Sain-Van Der Velden MG, Reijngoud DJ, Kaysen GA, Gadellaa MM, Voorbij H, Stellaard F, Koomans HA, Rabelink TJ. Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome. J Am Soc Nephrol. 1998 Aug; 9(8):1474-81. PMID: 9697670.
      View in: PubMed
    170. de Sain-van der Velden MG, Rabelink TJ, Reijngoud DJ, Gadellaa MM, Voorbij HA, Stellaard F, Kaysen GA. Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int. 1998 Aug; 54(2):530-5. PMID: 9690220.
      View in: PubMed
    171. de Sain-van der Velden MG, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HA, Reijngoud DJ, Rabelink TJ. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int. 1998 Apr; 53(4):994-1001. PMID: 9551409.
      View in: PubMed
    172. de Sain-van der Velden MG, Kaysen GA, de Meer K, Stellaard F, Voorbij HA, Reijngoud DJ, Rabelink TJ, Koomans HA. Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney Int. 1998 Jan; 53(1):181-8. PMID: 9453016.
      View in: PubMed
    173. Kaysen GA. Albumin turnover in renal disease. Miner Electrolyte Metab. 1998; 24(1):55-63. PMID: 9397418.
      View in: PubMed
    174. Stevenson FT, Greene S, Kaysen GA. Serum alpha 2-macroglobulin and alpha 1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms. Kidney Int. 1998 Jan; 53(1):67-75. PMID: 9453001.
      View in: PubMed
    175. Gades MD, Stern JS, van Goor H, Nguyen D, Johnson PR, Kaysen GA. Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int. 1998 Jan; 53(1):130-5. PMID: 9453009.
      View in: PubMed
    176. Kaysen GA, Webster S, Al-Bander H, Jones H, Hutchison FN. High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms. Miner Electrolyte Metab. 1998; 24(4):238-45. PMID: 9554562.
      View in: PubMed
    177. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis. 1997 Dec; 30(6):923-7. PMID: 9398142.
      View in: PubMed
    178. Kang JJ, Kaysen GA, Jones H, Holland MJ. Rat liver transcript profiling in normal and disease states using a kinetic polymerase chain reaction assay. Methods. 1997 Dec; 13(4):437-43. PMID: 9480787.
      View in: PubMed
    179. Letteri JM, Adams MB, Duffy M, Fedje L, Jacobs C, Kaysen G, Krohn BA, Norwood K, O'Connor P, Schiereth M, Witten B. Disaster preparedness for renal facilities and patients. Ren Fail. 1997 Sep; 19(5):673-85. PMID: 9380886.
      View in: PubMed
    180. Neverov NI, Kaysen GA, Nuccitelli R, Weiss RH. HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism. J Am Soc Nephrol. 1997 Aug; 8(8):1247-56. PMID: 9259351.
      View in: PubMed
    181. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997 May; 29(5):658-68. PMID: 9159298.
      View in: PubMed
    182. Kaysen GA, Yeun J, Depner T. Albumin synthesis, catabolism and distribution in dialysis patients. Miner Electrolyte Metab. 1997; 23(3-6):218-24. PMID: 9387121.
      View in: PubMed
    183. Neverov NI, Kaysen GA, Tareyeva IE. Effect of lipid-lowering therapy on the progression of renal disease in nondiabetic nephrotic patients. Contrib Nephrol. 1997; 120:68-78. PMID: 9257049.
      View in: PubMed
    184. Kaysen GA, Jones H, Joles JA, van Tol A. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis. Miner Electrolyte Metab. 1996; 22(1-3):31-8. PMID: 8676821.
      View in: PubMed
    185. Kaysen GA, Rathore V. Derangements of protein metabolism in chronic renal failure. Blood Purif. 1996; 14(5):373-81. PMID: 8894132.
      View in: PubMed
    186. Swislocki A, Eason T, Kaysen GA. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am J Hypertens. 1995 Oct; 8(10 Pt 1):1009-14. PMID: 8845069.
      View in: PubMed
    187. Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M. Effect of amlodipine on left ventricular mass in the Amlodipine Cardiovascular Community Trial. J Cardiovasc Pharmacol. 1995 Sep; 26(3):471-6. PMID: 8583790.
      View in: PubMed
    188. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995 Aug; 48(2):510-6. PMID: 7564120.
      View in: PubMed
    189. Kaysen GA, Hoye E, Jones H, van Tol A, Joles JA. Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat. Am J Kidney Dis. 1995 Jul; 26(1):178-86. PMID: 7611250.
      View in: PubMed
    190. Hirschberg R, Kaysen GA. Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology. 1995 Apr; 136(4):1565-71. PMID: 7534704.
      View in: PubMed
    191. Kaysen GA, Sun X, Jones H, Martin VI, Joles JA, Tsukamoto H, Couser WG, al-Bander H. Non-iron mediated alteration in hepatic transferrin gene expression in the nephrotic rat. Kidney Int. 1995 Apr; 47(4):1068-77. PMID: 7783403.
      View in: PubMed
    192. Kaysen GA, Hoye E, Jones H. Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats. Am J Physiol. 1995 Mar; 268(3 Pt 2):F532-40. PMID: 7900854.
      View in: PubMed
    193. Yu S, Beems RB, Joles JA, Kaysen GA, Beynen AC. Iron and copper metabolism in analbuminaemic rats fed a high-iron diet. Comp Biochem Physiol A Physiol. 1995 Feb; 110(2):131-8. PMID: 7704624.
      View in: PubMed
    194. Sun X, Kaysen GA. Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats. Kidney Int. 1994 May; 45(5):1381-7. PMID: 7520954.
      View in: PubMed
    195. Kaysen GA. Hyperlipidemia of chronic renal failure. Blood Purif. 1994; 12(1):60-7. PMID: 7986478.
      View in: PubMed
    196. Kaysen GA. Nonrenal complications of the nephrotic syndrome. Annu Rev Med. 1994; 45:201-10. PMID: 8198377.
      View in: PubMed
    197. Wiig H, Kaysen GA, al-Bander HA, De Carlo M, Sibley L, Renkin EM. Interstitial exclusion of IgG in rat tissues estimated by continuous infusion. Am J Physiol. 1994 Jan; 266(1 Pt 2):H212-9. PMID: 8304502.
      View in: PubMed
    198. Kaysen GA, Pan XM, Couser WG, Staprans I. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma. Am J Kidney Dis. 1993 Jul; 22(1):128-34. PMID: 8322775.
      View in: PubMed
    199. Joles JA, Feingold KR, Van Tol A, Cohen LH, Sun X, Jones H, Davies RW, Kaysen GA. Extrahepatic lipogenesis contributes to hyperlipidemia in the analbuminemic rat. Am J Physiol. 1993 Jul; 265(1 Pt 2):F70-6. PMID: 8342616.
      View in: PubMed
    200. Sun X, Martin V, Weiss RH, Kaysen GA. Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol. 1993 Mar; 264(3 Pt 2):F441-7. PMID: 7681261.
      View in: PubMed
    201. Renkin EM, Tucker VL, Wiig H, Kaysen G, Sibley L, DeCarlo M, Simanonok K, Wong M. Blood-tissue transport of exogenous albumin and immunoglobulin G in genetically analbuminemic rats. J Appl Physiol (1985). 1993 Feb; 74(2):559-66. PMID: 7681428.
      View in: PubMed
    202. Kaysen GA. The nephrotic syndrome: pathogenesis and consequences. The homeostatic and pathogenic consequences of proteinuria. Introduction. Am J Nephrol. 1993; 13(5):309-10. PMID: 8116682.
      View in: PubMed
    203. Kaysen GA. Plasma composition in the nephrotic syndrome. Am J Nephrol. 1993; 13(5):347-59. PMID: 8116687.
      View in: PubMed
    204. Kaysen GA, Martin VI, Jones H. Arginine augments neither albuminuria nor albumin synthesis caused by high-protein diets in nephrosis. Am J Physiol. 1992 Nov; 263(5 Pt 2):F907-14. PMID: 1443179.
      View in: PubMed
    205. Kaysen GA, Mehendru L, Pan XM, Staprans I. Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis. Am J Physiol. 1992 Aug; 263(2 Pt 2):F335-41. PMID: 1510125.
      View in: PubMed
    206. Sun X, Jones H, Joles JA, van Tol A, Kaysen GA. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol. 1992 May; 262(5 Pt 2):F755-61. PMID: 1590420.
      View in: PubMed
    207. al-Bander HA, Martin VI, Kaysen GA. Plasma IgG pool is not defended from urinary loss in nephrotic syndrome. Am J Physiol. 1992 Mar; 262(3 Pt 2):F333-7. PMID: 1558152.
      View in: PubMed
    208. Kaysen GA. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis. Miner Electrolyte Metab. 1992; 18(2-5):212-6. PMID: 1465061.
      View in: PubMed
    209. Kaysen GA, Carstensen A, Martin VI. Muscle protein synthesis is impaired in nephrotic rats. Miner Electrolyte Metab. 1992; 18(2-5):228-32. PMID: 1465064.
      View in: PubMed
    210. Al-Bander H, Kaysen GA. Ineffectiveness of dietary protein augmentation in the management of the nephrotic syndrome. Pediatr Nephrol. 1991 Jul; 5(4):482-6. PMID: 1911126.
      View in: PubMed
    211. Kaysen GA. Hyperlipidemia of the nephrotic syndrome. Kidney Int Suppl. 1991 Apr; 31:S8-15. PMID: 2046275.
      View in: PubMed
    212. Kaysen GA, al-Bander H, Martin VI, Jones H, Hutchison FN. Branched-chain amino acids augment neither albuminuria nor albumin synthesis in nephrotic rats. Am J Physiol. 1991 Feb; 260(2 Pt 2):R177-84. PMID: 1996710.
      View in: PubMed
    213. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome. Nephrol Dial Transplant. 1991; 6(2):141-9. PMID: 1857529.
      View in: PubMed
    214. Don BR, Kaysen GA, Hutchison FN, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis. 1991 Jan; 17(1):10-7. PMID: 1986564.
      View in: PubMed
    215. Kaysen GA, Davies RW. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome. J Am Soc Nephrol. 1990 Nov; 1(5 Suppl 2):S75-9. PMID: 16989070.
      View in: PubMed
    216. Kaysen GA, Hutchison FN, al Bander H. The effect of the nephrotic syndrome on the renal handling of protein and other nutrients. Semin Nephrol. 1990 Sep; 10(5):481-90. PMID: 2236990.
      View in: PubMed
    217. Davies RW, Staprans I, Hutchison FN, Kaysen GA. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest. 1990 Aug; 86(2):600-5. PMID: 2384606.
      View in: PubMed
    218. Hutchison FN, Martin VI, Jones H, Kaysen GA. Differing actions of dietary protein and enalapril on renal function and proteinuria. Am J Physiol. 1990 Jan; 258(1 Pt 2):F126-32. PMID: 2301589.
      View in: PubMed
    219. Kaysen GA, al Bander H. Metabolism of albumin and immunoglobulins in the nephrotic syndrome. Am J Nephrol. 1990; 10 Suppl 1:36-42. PMID: 2256474.
      View in: PubMed
    220. Kaysen GA, Jones H, Hutchison FN. High protein diets stimulate albumin synthesis at the site of albumin mRNA transcription. Kidney Int Suppl. 1989 Nov; 27:S168-72. PMID: 2561516.
      View in: PubMed
    221. Don BR, Wada L, Kaysen GA, Schambelan M. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney Int Suppl. 1989 Nov; 27:S163-7. PMID: 2561515.
      View in: PubMed
    222. Kaysen GA, Davies RW, Hutchison FN. Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis. Kidney Int Suppl. 1989 Nov; 27:S154-62. PMID: 2561514.
      View in: PubMed
    223. Kaysen GA, Rosenthal C, Hutchison FN. GFR increases before renal mass or ODC activity increase in rats fed high protein diets. Kidney Int. 1989 Sep; 36(3):441-6. PMID: 2593487.
      View in: PubMed
    224. Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M. Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med. 1989 May 15; 110(10):795-813. PMID: 2653154.
      View in: PubMed
    225. Kaysen GA, Jones H, Martin V, Hutchison FN. A low-protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest. 1989 May; 83(5):1623-9. PMID: 2708523.
      View in: PubMed
    226. Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol. 1989 Apr; 256(4 Pt 2):F711-8. PMID: 2539749.
      View in: PubMed
    227. Schambelan M, Don BR, Kaysen GA, Blake S. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration. Adv Exp Med Biol. 1989; 259:275-304. PMID: 2696356.
      View in: PubMed
    228. Kaysen GA. Hyperlipidemia in the nephrotic syndrome. Am J Kidney Dis. 1988 Dec; 12(6):548-51. PMID: 3195579.
      View in: PubMed
    229. Kaysen GA. Albumin metabolism in the nephrotic syndrome: the effect of dietary protein intake. Am J Kidney Dis. 1988 Dec; 12(6):461-80. PMID: 3057880.
      View in: PubMed
    230. Hutchison FN, Kaysen GA. Perinephric abscess: the missed diagnosis. Med Clin North Am. 1988 Sep; 72(5):993-1014. PMID: 3045458.
      View in: PubMed
    231. Hutchison FN, Kaysen GA. Albuminuria causes lysozymuria in rats with Heymann nephritis. Kidney Int. 1988 Apr; 33(4):787-91. PMID: 2838679.
      View in: PubMed
    232. Dubick MA, Majumdar AP, Kaysen GA, Burbige EJ, Geokas MC. Secretagogue-induced enzyme release from the exocrine pancreas of rats following adaptation to a high protein diet. J Nutr. 1988 Mar; 118(3):305-10. PMID: 2450976.
      View in: PubMed
    233. Hutchison FN, Perez EA, Gandara DR, Lawrence HJ, Kaysen GA. Renal salt wasting in patients treated with cisplatin. Ann Intern Med. 1988 Jan; 108(1):21-5. PMID: 3337511.
      View in: PubMed
    234. Hutchinson FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol. 1987 Oct; 253(4 Pt 2):F719-25. PMID: 2821830.
      View in: PubMed
    235. Kaysen GA, Gambertoglio J, Felts J, Hutchison FN. Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients. Kidney Int. 1987 Jun; 31(6):1368-76. PMID: 3613408.
      View in: PubMed
    236. Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17B:725-8. PMID: 2960179.
      View in: PubMed
    237. Hughes-Fulford M, Feingold KR, Searle GL, Wu J, Siperstein MD, Schoenfeld PY, Kaysen G. Role of the kidneys in the metabolism of circulating mevalonate in humans. J Clin Endocrinol Metab. 1986 Jun; 62(6):1227-31. PMID: 3084536.
      View in: PubMed
    238. Kaysen GA, Myers BD, Couser WG, Rabkin R, Felts JM. Mechanisms and consequences of proteinuria. Lab Invest. 1986 May; 54(5):479-98. PMID: 3517485.
      View in: PubMed
    239. Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int. 1986 Feb; 29(2):572-7. PMID: 3702214.
      View in: PubMed
    240. Mickelson JK, Carlson CJ, Kaysen GA, Rapaport E. Creatine kinase: purification, characterization, and tissue distribution of the MM subtypes. Clin Chim Acta. 1985 Dec 31; 153(3):181-90. PMID: 4075524.
      View in: PubMed
    241. Kaysen GA, Pond SM, Roper MH, Menke DJ, Marrama MA. Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. Arch Intern Med. 1985 Nov; 145(11):2019-23. PMID: 4062453.
      View in: PubMed
    242. Kaysen GA, Majumdar AP, Dubick MA, Vesenka GD, Mar G, Geokas MC. Biochemical changes in the pancreas of rats with chronic renal failure. Am J Physiol. 1985 Oct; 249(4 Pt 2):F518-23. PMID: 2413775.
      View in: PubMed
    243. Kaysen GA, Myers BD. The aging kidney. Clin Geriatr Med. 1985 Feb; 1(1):207-22. PMID: 3913500.
      View in: PubMed
    244. Kaysen GA, Paukert TT, Menke DJ, Couser WG, Humphreys MH. Plasma volume expansion is necessary for edema formation in the rate with Heymann nephritis. Am J Physiol. 1985 Feb; 248(2 Pt 2):F247-53. PMID: 3970214.
      View in: PubMed
    245. Kaysen GA, Kirkpatrick WG, Couser WG. Albumin homeostasis in the nephrotic rat: nutritional considerations. Am J Physiol. 1984 Jul; 247(1 Pt 2):F192-202. PMID: 6742202.
      View in: PubMed
    246. Zern MA, Yap SH, Strair RK, Kaysen GA, Shafritz DA. Effects of chronic renal failure on protein synthesis and albumin messenger ribonucleic acid in rat liver. J Clin Invest. 1984 Apr; 73(4):1167-74. PMID: 6707209.
      View in: PubMed
    247. Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1984 Jan; 25(1):107-14. PMID: 6727122.
      View in: PubMed
    248. Kaysen G, Noth RH. The effects of alcohol on blood pressure and electrolytes. Med Clin North Am. 1984 Jan; 68(1):221-46. PMID: 6361414.
      View in: PubMed
    249. Vincenti F, Amend WJ, Kaysen G, Feduska N, Birnbaum J, Duca R, Salvatierra O. Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation. 1983 Dec; 36(6):626-9. PMID: 6659058.
      View in: PubMed
    250. Feingold KR, Wiley MH, MacRae G, Kaysen G, Schoenfeld PY, Siperstein MD. The effect of uremia on circulating mevalonate metabolism in rats. Metabolism. 1983 Mar; 32(3):215-23. PMID: 6827993.
      View in: PubMed
    251. Kaysen GA, Kropp J. Dietary tryptophan supplementation prevents proteinuria in the seven-eighths nephrectomized rat. Kidney Int. 1983 Mar; 23(3):473-9. PMID: 6842966.
      View in: PubMed
    252. Kaysen GA, Watson JB. Mechanism of hypoalbuminemia in the 7/8-nephrectomized rat with chronic renal failure. Am J Physiol. 1982 Oct; 243(4):F372-8. PMID: 7124950.
      View in: PubMed
    253. Benowitz NL, Osterloh J, Goldschlager N, Kaysen G, Pond S, Forhan S. Massive catecholamine release from caffeine poisoning. JAMA. 1982 Sep 03; 248(9):1097-8. PMID: 7109204.
      View in: PubMed
    254. Clendeninn NJ, Pond SM, Kaysen G, Barraza JJ, Farrell T, Becker CE. Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol Clin Toxicol. 1982 Jun; 19(4):341-52. PMID: 7143521.
      View in: PubMed
    255. Pond SM, Tong TG, Kaysen GA, Menke DJ, Galinsky RE, Roberts SM, Levy G. Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol. 1982 Mar; 19(1):1-16. PMID: 7154136.
      View in: PubMed
    256. Humphreys MH, Kaysen GA, Chou LY, Watson JB. Anion-stimulated phosphohydrolase activity of intestinal alkaline phosphatase. Am J Physiol. 1980 Jan; 238(1):G3-9. PMID: 6153512.
      View in: PubMed
    257. Kaysen GA, Chou LY, Humphreys MH. Requirement of Zn to demonstrate HCO3-stimulated ATPase activity of rat small intestinal brush border. J Cell Biol. 1979 Sep; 82(3):780-2. PMID: 159907.
      View in: PubMed
    258. Kaysen GA, Strecker HJ. Purification and properties of arginase of rat kidney. Biochem J. 1973 Aug; 133(4):779-88. PMID: 4748833.
      View in: PubMed
    259. Englard S, Kaysen G, Avigad G. 5-keto-D-fructose. VI. A specific reduced nicotinamide adenine dinucleotide phosphate-linked reductase from yeast. J Biol Chem. 1970 Mar 25; 245(6):1311-8. PMID: 4392628.
      View in: PubMed